ATI LPN
Pharmacology and the Nursing Process 10th Edition Test Bank
Chapter 51 : Bowel Disorder Drugs Questions
Question 1 of 5
A patient is taking linaclotide to treat irritable bowel syndrome (IBS). The nurse will monitor this patient for which adverse effect?
Correct Answer: C
Rationale: Common adverse effects of linaclotide (Linzess) are diarrhea, abdominal pain, and flatulence. Elevated blood glucose levels, chest pain, and chronic constipation are not adverse effects of linaclotide.
Question 2 of 5
The nurse is preparing to administer methylnaltrexone. This drug is appropriate for which patient?
Correct Answer: B
Rationale: Methylnaltrexone is approved only for terminally ill (hospice) patients who have opioid-induced constipation. The other options are incorrect.
Question 3 of 5
A patient has been treated with alosetron for severe irritable bowel syndrome for 2 weeks. She calls the clinic and tells the nurse that she has been experiencing constipation for 3 days. The nurse will take which action?
Correct Answer: C
Rationale: Alosetron must be discontinued immediately if constipation or signs of ischemic colitis occur. The other options are incorrect.
Question 4 of 5
The nurse is reviewing the uses of oral laxatives. Which conditions are general contraindications to or cautions about the use of oral laxatives? (Select all that apply.)
Correct Answer: B,C,D,F
Rationale: Cautious use of laxatives is recommended in the presence of these: acute surgical abdomen; appendicitis symptoms, such as abdominal pain, nausea, and vomiting; intestinal obstruction; and undiagnosed abdominal pain. Oral laxatives must not be used with fecal impaction; mineral oil enemas are indicated for fecal impaction. The other options are indications for other laxative use.
Question 5 of 5
A patient will be receiving docusate sodium, 120 mg/day PO, divided into 3 doses. Identify how many milligrams will this patient receive per dose.
Correct Answer: 40 mg
Rationale: 120 mg/day ?· 3 doses/day = 40 mg.